Human HLA-G Complex Tetramer protein (Recombinant) (C-His&Avi) (STJP020307)
SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant Human HLA-G Complex Tetramer Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal, tetramer is assembled by biotinylated monomer and streptavidin.οΌIt contains Gly25-Thr305 (HLA-G) , Ile21-Met119 (B2M) and RIIPRHLQL
General Information
| Short Description | Recombinant-Human HLA-G Complex Tetramer-C-His&Avi protein was developed in hek293 cells using the region Gly25-Thr305. For use in research applications. |
| Host | HEK293 cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Storage Instruction | Store at-20Β°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | < 1 EU/Mu g of the protein by LAL method. |
Target Information
| Immunogen | Recombinant Human HLA-G Complex Tetramer Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal, tetramer is assembled by biotinylated monomer and streptavidin.οΌIt contains Gly25-Thr305 (HLA-G) , Ile21-Met119 (B2M) and RIIPRHLQL |
| Immunogen Region | Gly25-Thr305 |
Additional Info
| Background | HLA-G is a molecule that was first known to confer protection to the fetus from destruction by the immune system of its mother, thus critically contributing to fetal-maternal tolerance. The first functional finding constituted the basis for HLA-G research and can be summarized as such: HLA-G, membrane-bound or soluble, strongly binds its inhibitory receptors on immune cells (NK, T, B, monocytes/dendritic cells) , inhibits the functions of these effectors, and so induces immune inhibition. |
Information sourced from Uniprot.org